Please contact Dr. Works (keworks@fsu.eu) for additional help: Submission navigation links for Research Symposium Program Portal WF ‹ Previous submission Next submission › Submission information Submission Number: 58 Submission ID: 7821 Submission UUID: 73ce831f-6177-4d54-9ac2-35897a059ba4 Submission URI: /student-research/symposium/research-symposium-program-portal Submission Update: /student-research/symposium/research-symposium-program-portal?token=cNNwtN9MQPBijnLDxmJEPojdtQqGPmh1arTgdDquD80 Created: Wed, 02/05/2025 - 05:19 PM Completed: Wed, 02/05/2025 - 05:29 PM Changed: Tue, 04/01/2025 - 08:31 AM Remote IP address: 67.146.133.52 Submitted by: Anonymous Language: English Is draft: No Webform: Research Symposium Program Portal WF Submitted to: Student Research Symposium Program Portal Primary Student Contact First Name Primary Student Contact Last Name Pronouns Primary Student Contact FSU Student Email Photo of all individuals presenting this work IMG_4367.jpg779.44 KB Remove Upload requirementsOne file only.2 MB limit. Major(s) of all individuals presenting this work Bio of all individuals presenting this work I am a student in the Class of 2025- Doctor of Nurse Anesthesia Practice at Florida State University. I am passionate about the practice of anesthesia and furthering evidence based practice through research. I plan to practice in my hometown of Dothan, Alabama upon graduation. Poster Title Abstract Neuromuscular blockade (NMB) reversal is vital for anesthesia care to prevent residual blockade, which can lead to respiratory complications and delayed recovery. This quality improvement project evaluated sugammadex, a selective NMB reversal agent, compared to the traditional neostigmine-glycopyrrolate, focusing on postoperative care unit (PACU) times in adult patients undergoing general anesthesia with rocuronium or vecuronium. Evidence from clinical guidelines and studies supported sugammadex's advantages in efficiency, safety, and cost-effectiveness. Implemented at a facility in Dothan, Alabama, the project addressed financial concerns through education, aiming to increase sugammadex utilization. Usage increased modestly by 1.38% (from 434 to 440 cases), reflecting improved provider confidence and highlighting the value of overcoming barriers to enhance patient safety and operating room efficiency. Research Mentor Name Research Mentor's College (or High School) Research Mentor's Department (or Subject) Research Mentor's Email Additional Research Mentor(s) Co-presenter(s) Keywords Poster Session/Number Work Complete Exploratory (the research question has been identified and design of approach is outlined) Presentation Modality Face to Face Poster session Synchronous Online Presentation Asynchronous Online Presentation Poster PDF DNAP Poster .pdf503.28 KB Remove Upload requirementsOne file only.100 MB limit. Poster Thumbnail Screen Shot 2025-02-05 at 4.28.38 PM.png703.92 KB Remove Upload requirementsOne file only.2 MB limit. I will be printing my poster CAPTCHA What code is in the image? Enter the characters shown in the image. This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Save Leave this field blank
